ArticleCureus2025
Validity of Intraoperative Imprint Cytology and Frozen Section for Sentinel Lymph Node Assessment in Breast Cancer: A Single-Centre Experience.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSentinel lymph node (SLN) evaluation is central to breast cancer management. Intraoperative touch imprint cytology (TIC) and frozen section (FS) are standard, rapid techniques; however, their performance compared to the gold standard of histopathology in Sri Lanka is underreported. This study evaluates the validity of intraoperative TIC and FS in identifying SLN metastases in patients with breast cancer.
methodsWe retrospectively analysed 416 SLN biopsies (2018-2020), with all cases assessed by TIC, FS, and subsequent paraffin histology. Demographic and clinicopathologic features were correlated with diagnostic metrics.
resultsMean patient age was 55.9 years. Tumour sizes were ≤20 mm in 23.6%, 21-50 mm in 66.6%, and ≥50 mm in 9.9%. Most cases (92.1%) were invasive carcinoma of no special type (NST). Sensitivity and specificity for TIC were 90.6% and 100%; for FS, 92.7% and 100%. Combined TIC+FS yielded a sensitivity of 92.7% and a specificity of 100%. Detection rates for micrometastases were lower, and sensitivity for TIC was reduced in cases of lobular carcinoma and those where no LVI was found in the primary tumour.
conclusionBoth TIC and FS individually showed high sensitivity (90.6% and 92.7%, respectively) and perfect specificity (100%) in the detection of metastatic deposits in SLNs. Combining TIC and FS maintained excellent specificity, while also maintaining the same sensitivity as FS alone. All three methods demonstrated consistently strong predictive values and overall accuracy, with limitations for smaller deposits and specific subtypes, such as invasive lobular carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.